The intranasal GHK-Cu treatment was found to delay cognitive impairment, reduce amyloid plaques, and lower inflammation levels in the frontal cortex and hippocampus .37 Randomized controlled trials in human patients are needed to confirm the benefit of GHK-Cu for cognitive decline and Alzheimers disease as well as to evaluate safe and effective human dosing (the human dose equivalent of 15mg/kg in mice would be ~1.2mg/kg, though data on this or any other dosing nasally in humans is not currently available), but preliminary animal trials are promising
c ch hot ng ca Glutathione y l mt cht chng oxy ha mnh, c mt hu ht cc t bo trong c th, ng vai tr quan trng trong vic trung ha cc gc t do, gii c gan v h tr h min dch
10.1007/s00213-023-06466-9 276 LiddelowS
Before considering one, it is worth being clear-eyed: using IV glutathione to lighten skin is not a licensed medical treatment, the long-term safety evidence is limited, and several regulators have raised concerns
He is passionate about improving patient outcomes by providing precise, reliable care and fostering open communication
Need et al., 2012
